Home > Drug Search >
  • company_query: Allyence Research
  •   > 
Drug Filter
Category:
chemistry (8) biology (22)
Status:
Approved (1) Phase Ⅲ (1) Phase Ⅱ (10) Phase Ⅰ (18)
Clinical Stage:
Pending (4) Active (24) Discontinued (1)
Bio-Type:
Gene therapy (1) Vaccine (17) Whole antibody (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Allergic rhinoconjunctivitis (1) Atopic dermatitis (1) Breast cancer (1) Cancer related pain (1) Chronic obstructive pulmonary disease (COPD) (1) Chronic pain (1) Eczema (1) HIV infection (4) Influenza virus infection (1) Melanoma (1) Myelodysplastic syndrome (MDS) (1) Ovarian cancer (1) Neuroprotection (1) Psoriasis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (1) Solid tumours (3) Erythema (1) Cervical intraepithelial neoplasia (1) Influenza A virus infections (2) Inborn genetic disorders (1) Anthrax (1) Gram-negative bacterial infection (1) Enterovirus infection (1) West nile virus infection (1) Dengue fever (1) Bacterial infection (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top